Cassava Sciences Inc (NASDAQ:SAVA)

30.92
Delayed Data
As of Feb 03
 -0.02 / -0.06%
Today’s Change
13.84
Today|||52-Week Range
62.49
+4.67%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$1.3B

Company Description

Cassava Sciences, Inc. engages in the development of novel drugs and diagnostics. It focuses on developing product candidates intended for the treatment of Alzheimer's disease, including PTI-125 and PTI-125Dx. The company was founded by Remi Barbier and Barry M. Sherman in May 1998 and is headquartered in Austin, TX.

Contact Information

Cassava Sciences, Inc.
6801 North Capital of Texas Highway
Austin Texas 78731
P:(512) 501-2444
Investor Relations:
(512) 501-2450

Employees

Shareholders

Individual stakeholders6.12%
Mutual fund holders15.25%
Other institutional11.36%

Top Executives

Remi BarbierChairman, President & Chief Executive Officer
Eric J. SchoenChief Financial Officer
James W. KupiecChief Medical Officer
Michael ZamlootSenior Vice President-Technical Operations
George B. ThorntonSenior Vice President-Technology